ARCHIVES

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

ACOS Survey To Assess Tumor Boards’ Impact On Patient Care

January 24, 1986

Edelson To Step Down As Yale Center Director.

January 11, 2008

Breast Cancer Progress Report Summaries

November 14, 1975

NIH Carcinogen Guidelines Offered

April 24, 1981

Survey Finds 70 Percent of Oncologists Prescribe Avastin Off-Label For Ovarian Cancer

August 30, 2013

DCPC Bard Approves Concepts For New Minority Enhancement Awards Program, Two RFA Reissues

January 22, 1988